Shares of Encompass Health Corp (AMEX:EHC) have received an average recommendation of “Buy” from the eleven brokerages that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $76.38.
A number of equities research analysts recently weighed in on the stock. Zacks Investment Research raised shares of Encompass Health from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a research report on Monday, December 24th. Jefferies Financial Group assumed coverage on shares of Encompass Health in a research report on Thursday, December 20th. They set a “buy” rating for the company. Finally, Barclays assumed coverage on shares of Encompass Health in a research report on Friday, December 14th. They set an “equal weight” rating and a $75.00 price objective for the company.
Encompass Health has a 1 year low of $40.86 and a 1 year high of $59.29.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Monday, April 1st will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of ∞. The ex-dividend date of this dividend is Friday, March 29th.
In other Encompass Health news, Director Leo I. Higdon, Jr. acquired 1,000 shares of the stock in a transaction that occurred on Thursday, March 7th. The stock was acquired at an average price of $58.84 per share, with a total value of $58,840.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in Encompass Health by 2.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,285,576 shares of the company’s stock valued at $723,811,000 after purchasing an additional 200,890 shares during the period. Morgan Stanley boosted its stake in Encompass Health by 25.8% during the 3rd quarter. Morgan Stanley now owns 638,008 shares of the company’s stock valued at $49,731,000 after purchasing an additional 130,728 shares during the period. Rehmann Capital Advisory Group boosted its stake in Encompass Health by 8,546.8% during the 3rd quarter. Rehmann Capital Advisory Group now owns 193,082 shares of the company’s stock valued at $2,477,000 after purchasing an additional 190,849 shares during the period. Nordea Investment Management AB boosted its stake in Encompass Health by 13.6% during the 3rd quarter. Nordea Investment Management AB now owns 57,325 shares of the company’s stock valued at $4,468,000 after purchasing an additional 6,856 shares during the period. Finally, TIAA CREF Investment Management LLC boosted its stake in Encompass Health by 5.0% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 1,362,083 shares of the company’s stock valued at $106,174,000 after purchasing an additional 64,497 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Read More: Beta
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.